BioNTech

National information platform on anti-COVID vaccination: BioNTech-Pfizer vaccine to be used after careful scientific evaluation

The national information platform on vaccination against COVID-19 informed on Thursday that the BioNTech-Pfizer vaccine will be used in the European Union only after a careful scientific evaluation attesting that it meets all the conditions provided for in the existing rules.

Greece expects 300,000 vaccine doses in first batch

Greece expects to receive 300,000 Covid-19 vaccine doses in the first tranche, which means that 150,000 people will be vaccinated initially (vaccines will require two doses per patient), government spokesman Stelios Petsas told Parapolitika radio on Wednesday. 

Petsas said that the immunization program will be launched in December or January.

Europe pushes for coronavirus vaccine roll-out as risky holiday season looms

European nations vowed on Dec. 16 to get their coronavirus vaccination campaigns rolling before the end of the year while a surge in infections prompted tighter restrictions across several countries.

Germany will begin vaccinations on December 27, its health minister said, detailing a timeline expected to be mirrored across the European Union's 27 member states.

FT selects vaccine founders Şahin, Türeci as People of the Year

The Financial Times has selected Turkish-German scientists Uğur Şahin and Özlem Türeci, who are at the helm of developing the world's first effective coronavirus vaccine, as 2020 People of the Year.

They are the symbol of a remarkable scientific and business success story, said the Financial Times.

Pages